Proteon Therapeutics, Inc.
(NASDAQ : PRTO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.29%94.031.3%$971.17m
BIIBBiogen Inc.
-0.69%225.621.3%$898.70m
GILDGilead Sciences, Inc.
-0.82%62.730.9%$410.84m
AMGNAmgen Inc.
-2.50%177.911.2%$409.45m
ILMNIllumina, Inc.
-0.11%318.343.5%$277.16m
REGNRegeneron Pharmaceuticals, Inc.
-2.88%333.102.6%$235.60m
VRTXVertex Pharmaceuticals Incorporated
0.37%167.581.9%$220.89m
ONCESpark Therapeutics, Inc.
-0.18%110.5111.2%$169.47m
ALXNAlexion Pharmaceuticals, Inc.
-0.36%125.462.0%$164.75m
EXASExact Sciences Corporation
0.84%92.5825.3%$152.38m
SRPTSarepta Therapeutics, Inc.
-1.86%116.5314.7%$138.76m
AAgilent Technologies, Inc.
1.07%76.241.6%$121.38m
INCYIncyte Corporation
-1.71%73.052.5%$90.39m
IONSIonis Pharmaceuticals, Inc.
-0.07%72.628.3%$88.30m
BMRNBioMarin Pharmaceutical Inc.
0.46%82.734.3%$85.02m

Company Profile

Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 and is headquartered in Waltham, MA.